
Sign up to save your podcasts
Or


74% of MASH patients achieved disease resolution with tirzepatide in new trials. We explore how Mounjaro and Zepbound reverse liver scarring, reduce fibrosis, and offer hope for the 30% of Americans with fatty liver disease. From friend Jerry's diagnosis story to clinical trial data, learn why this GLP-1 medication could transform liver treatment forever.
#FattyLiver #LiverDisease #Mounjaro #MASH #GLP1
https://mylifeonglp1.com/fatty-liver-disease/
https://mylifeonglp1.com/
By Scott Johnson4.4
1111 ratings
74% of MASH patients achieved disease resolution with tirzepatide in new trials. We explore how Mounjaro and Zepbound reverse liver scarring, reduce fibrosis, and offer hope for the 30% of Americans with fatty liver disease. From friend Jerry's diagnosis story to clinical trial data, learn why this GLP-1 medication could transform liver treatment forever.
#FattyLiver #LiverDisease #Mounjaro #MASH #GLP1
https://mylifeonglp1.com/fatty-liver-disease/
https://mylifeonglp1.com/

330 Listeners

162 Listeners

1,406 Listeners

47 Listeners

84 Listeners

1,654 Listeners

391 Listeners

223 Listeners

199 Listeners

292 Listeners

96 Listeners

158 Listeners

16 Listeners

27 Listeners

16 Listeners